XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 66,172 $ 79,506
Marketable securities 438,313 446,729
Trade accounts receivable, net of allowance for credit losses of $38,302 and $41,205 43,549 52,749
Other current assets 32,689 48,889
Total current assets 580,723 627,873
Marketable securities, long-term 366,833 326,648
Redeemable preferred stock investment 12,982 12,385
Fixed assets, net 79,083 81,353
Intangible assets, net 148,699 150,643
Goodwill 143,120 143,027
Other long-term assets 45,327 44,124
Total assets 1,376,767 1,386,053
Current liabilities    
Accounts payable 22,080 23,093
Accrued liabilities 21,088 24,981
Contract liabilities 2,733 3,199
Customer deposit 11,621 10,895
Investment margin loan 14,999 14,999
Notes payable, current portion 5,608 5,639
Other current liabilities 3,810 5,301
Total current liabilities 81,939 88,107
Unrecognized tax benefits 9,836 9,836
Other long-term liabilities 16,073 18,235
Total liabilities 107,848 116,178
Commitments and contingencies (Note 8)
Stockholders’ equity    
Common stock, $0.0001 par value per share, 50,000 shares authorized, 31,502 and 31,248 shares issued, respectively, and 29,692 and 29,438 shares outstanding, respectively 3 3
Preferred stock, $0.0001 par value per share, 1,000 shares authorized, no shares issued or outstanding
Additional paid-in capital 495,981 486,585
Accumulated other comprehensive loss (17,196) (20,903)
Retained earnings 785,660 801,000
Total Fulgent stockholders' equity 1,264,448 1,266,685
Noncontrolling interest 4,471 3,190
Total stockholders’ equity 1,268,919 1,269,875
Total liabilities and stockholders’ equity $ 1,376,767 $ 1,386,053